P3-084: Second-line treatment of Non-Small Cell Lung Cancer (NSCLC) with erlotinib is potentially cost-saving for the German healthcare system
Gatzemeier, Ulrich, Pirk, Olaf, Gabriel, Anja, Erhardt, Wilma, Kotowa, WiolettaVolume:
2
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1097/01.JTO.0000284060.34233.19
Date:
August, 2007
File:
PDF, 181 KB
english, 2007